Together for the greater goods: legitimising social innovation in the pharmaceutical field

References

• Abad, Ander Gurrutxaga, and Auxkin Galarraga Ezponda. 2022. “Controversies in Social Innovation Research.” Innovation: The European Journal of Social Science Research 35 (2): 224–244. https://doi.org/10.1080/13511610.2021.1964348.
   Web of Science ®Google Scholar
• Abraham, John. 2008. “Sociology of Pharmaceuticals Development and Regulation: A Realist Empirical Research Programme.” Sociology of Health & Illness 30 (6): 869–885. https://doi.org/10.1111/j.1467-9566.2008.01101.x.
   PubMed Web of Science ®Google Scholar
• Aldrich, Howard E., and C. Marlene Fiol. 1994. “Fools Rush in? The Institutional Context of Industry Creation.” The Academy of Management Review 19 (4): 645–670. https://doi.org/10.2307/258740.
   Web of Science ®Google Scholar
• Anheier, Helmut K., Gorgi Krlev, and Georg Mildenberger. 2019. ‘Social Innovation’. Comparative Perspectives. NY: Routledge.
   Google Scholar
• Arts, Irma, Arjen E. Buijs, and Gerard Verschoor. 2018. “Regimes of Justification: Competing Arguments and the Construction of Legitimacy in Dutch Nature Conservation Practices.” Journal of Environmental Planning and Management 61 (5-6): 1070–1084. https://doi.org/10.1080/09640568.2017.1319346.
   Web of Science ®Google Scholar
• Avelino, Flor, Julia M. Wittmayer, Bonno Pel, Paul Weaver, Adina Dumitru, Alex Haxeltine, René Kemp, et al. 2019. “Transformative Social Innovation and (Dis)Empowerment.” Technological Forecasting and Social Change 145 (August): 195–206. https://doi.org/10.1016/j.techfore.2017.05.002.
   Web of Science ®Google Scholar
• Barnes, Barry, and David Bloor. 1982. “Relativism, Rationalism, and the Sociology of Knowledge.” In Rationality and Relativism, edited by M. Hollis and S. Lukes, 21–47. Oxford: Basil Blackwell.
   Google Scholar
• Barnes, Barry, and Steven Shapin. 1979. “Natural Order: Historical Studies of Scientific Culture.” (No Title).
   Google Scholar
• Bitektine, Alex, and Patrick Haack. 2014. “The “Macro” and the “Micro” of Legitimacy: Toward a Multilevel Theory of the Legitimacy Process.” Academy of Management Review 40 (1): 49–75. https://doi.org/10.5465/amr.2013.0318
   Web of Science ®Google Scholar
• Bloor, David. 1991. Knowledge and Social Imagery. Chicago: University of Chicago Press.
   Google Scholar
• Boltanski, Luc, and Laurent Thévenot. 2006. On Justification: Economies of Worth. Princeton: Princeton University Press.
   Google Scholar
• Boon, Wouter, and Ellen Moors. 2008. “Exploring Emerging Technologies Using Metaphors – A Study of Orphan Drugs and Pharmacogenomics.” Social Science & Medicine 66 (9): 1915–1927. https://doi.org/10.1016/j.socscimed.2008.01.012.
   PubMed Web of Science ®Google Scholar
• Borup, Mads, Nik Brown, Kornelia Konrad, and Harro Van Lente. 2006. “The Sociology of Expectations in Science and Technology.” Technology Analysis & Strategic Management 18 (3-4): 285–298. https://doi.org/10.1080/09537320600777002.
   Web of Science ®Google Scholar
• Brabers, Anne E. M., Ellen H. M. Moors, Sonja van Weely, and Remco L. A. de Vrueh. 2011. “Molecular Analysis and Intestinal Expression of SAR1 Genes and Proteins in Anderson’s Disease (Chylomicron Retention Disease)” Orphanet Journal of Rare Diseases 6 (1): 1–11. https://doi.org/10.1186/1750-1172-6-1.
   PubMedGoogle Scholar
• Braun, M. Miles, Sheiren Farag-El-Massah, Kui Xu, and Timothy R. Coté. 2010. “Emergence of Orphan Drugs in the United States: A Quantitative Assessment of the First 25 Years.” Nature Reviews Drug Discovery 9 (7): 519–522. https://doi.org/10.1038/nrd3160.
   PubMed Web of Science ®Google Scholar
• Brown, Nik, and Mike Michael. 2003. “A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects.” Technology Analysis & Strategic Management 15 (1): 3–18. https://doi.org/10.1080/0953732032000046024.
   Web of Science ®Google Scholar
• Bunnik, Eline M., Nikkie Aarts, and Suzanne van de Vathorst. 2018. “Little to Lose and No Other Options: Ethical Issues in Efforts to Facilitate Expanded Access to Investigational Drugs.” Health Policy 122 (9): 977–983. https://doi.org/10.1016/j.healthpol.2018.06.005.
   PubMed Web of Science ®Google Scholar
• Cajaiba-Santana, Giovany. 2014. “Social Innovation: Moving the Field Forward. A Conceptual Framework.” Technological Forecasting and Social Change 82 (February): 42–51. https://doi.org/10.1016/j.techfore.2013.05.008.
   Google Scholar
• Callon, Michel. 1984. “Some Elements of a Sociology of Translation: Domestication of the Scallops and the Fishermen of St Brieuc Bay.” The Sociological Review 32 (1_suppl): 196–233. https://doi.org/10.1111/j.1467-954X.1984.tb00113.x
   Web of Science ®Google Scholar
• Campomori, Francesca, and Mattia Casula. 2022. “How to Frame the Governance Dimension of Social Innovation: Theoretical Considerations and Empirical Evidence.” Innovation: The European Journal of Social Science Research 36 (2): 171–189. https://doi.org/10.1080/13511610.2022.2036952.
   Web of Science ®Google Scholar
• Charmaz, Kathy. 2000. “Grounded Theory: Objectivist and Constructivist Methods.” Handbook of Qualitative Research 2 (1): 509–535.
   Google Scholar
• Collins, Harry M. 1983. “The Sociology of Scientific Knowledge: Studies of Contemporary Science.” Annual Review of Sociology 9 (1): 265–285. https://doi.org/10.1146/annurev.so.09.080183.001405
   Google Scholar
• Connelly, Steve, Tim Richardson, and Tim Miles. 2006. “Situated Legitimacy: Deliberative Arenas and the New Rural Governance.” Journal of Rural Studies 22 (3): 267–277. https://doi.org/10.1016/j.jrurstud.2005.11.008.
   Web of Science ®Google Scholar
• Coppens, Delphi G. M., Jarno Hoekman, Marie L. De Bruin, C. M. Ineke, Hubert G. M Slaper-Cortenbach, Pauline Meij Leufkens, and Helga Gardarsdottir. 2020. “Advanced Therapy Medicinal Product Manufacturing Under the Hospital Exemption and Other Exemption Pathways in Seven European Union Countries.” Cytotherapy 22 (10): 592–600. https://doi.org/10.1016/j.jcyt.2020.04.092.
   PubMed Web of Science ®Google Scholar
• Côté, André, and Bernard Keating. 2012. “What is Wrong with Orphan Drug Policies?” Value in Health 15 (8): 1185–1191. https://doi.org/10.1016/j.jval.2012.09.004.
   PubMed Web of Science ®Google Scholar
• Creswell, John W., and Cheryl N. Poth. 2017. Qualitative Inquiry and Research Design: Choosing among Five Approaches. London: Sage Publications.
   Google Scholar
• de Freitas, Cláudia, Vanessa dos Reis, Susana Silva, Paula A. Videira, Eva Morava, and Jaak Jaeken. 2017. “Public and Patient Involvement in Needs Assessment and Social Innovation: A People-Centred Approach to Care and Research for Congenital Disorders of Glycosylation.” BMC Health Services Research 17 (1): 682. https://doi.org/10.1186/s12913-017-2625-1.
   PubMedGoogle Scholar
• DiMaggio, Paul J., and Walter W. Powell. 1983. “The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields.” American Sociological Review 48 (2): 147–160. https://doi.org/10.2307/2095101.
   Web of Science ®Google Scholar
• Douglas, Conor M. W., Fernando Aith, Wouter Boon, Marina de Neiva Borba, Liliana Doganova, Shir Grunebaum, Rob Hagendijk, et al. 2022. “Social Pharmaceutical Innovation and Alternative Forms of Research, Development and Deployment for Drugs for Rare Diseases.” Orphanet Journal of Rare Diseases 17 (1): 344. https://doi.org/10.1186/s13023-022-02476-6.
   PubMed Web of Science ®Google Scholar
• Drori, Israel, and Benson Honig. 2013. “A Process Model of Internal and External Legitimacy.” Organization Studies 34 (3): 345–376. https://doi.org/10.1177/0170840612467153.
   Web of Science ®Google Scholar
• European Commission. 2014. “Social Innovation – A Decade of Changes.” espas.secure.europarl.europa.eu/orbis/sites/default/files/generated/document/en/social_innovation_decade_of_changes.pdf.
   Google Scholar
• Farmer, Jane, Karen Carlisle, Virginia Dickson-Swift, Simon Teasdale, Amanda Kenny, Judy Taylor, Felicity Croker, Karen Marini, and Mark Gussy. 2018. “Applying Social Innovation Theory to Examine How Community Co-Designed Health Services Develop: Using a Case Study Approach and Mixed Methods.” BMC Health Services Research 18 (1): 68. https://doi.org/10.1186/s12913-018-2852-0.
   PubMed Web of Science ®Google Scholar
• Faulkner, Alex. 2012. “Steering Biomedicine: Regulatory Dynamics of Therapeutic Technologies in the European Union and Beyond.” Innovation: The European Journal of Social Science Research 25 (4): 355–361. https://doi.org/10.1080/13511610.2012.730226.
   Web of Science ®Google Scholar
• Fougère, Martin, Beata Segercrantz, and Hannele Seeck. 2017. “A Critical Reading of the European Union’s Social Innovation Policy Discourse: (Re)Legitimizing Neoliberalism.” Organization 24 (6): 819–843. https://doi.org/10.1177/1350508416685171.
   Web of Science ®Google Scholar
• Galego, Diego, Frank Moulaert, Marleen Brans, and Gonçalo Santinha. 2022. “Social Innovation & Governance: A Scoping Review.” Innovation: The European Journal of Social Science Research 35 (2): 265–290. https://doi.org/10.1080/13511610.2021.1879630.
   Web of Science ®Google Scholar
• Garud, Raghu, Henri A. Schildt, and Theresa K. Lant. 2014. “Entrepreneurial Storytelling, Future Expectations, and the Paradox of Legitimacy.” Organization Science 25 (5): 1479–1492. https://doi.org/10.1287/orsc.2014.0915.
   Web of Science ®Google Scholar
• Geels, Frank, and Bram Verhees. 2011. “Cultural Legitimacy and Framing Struggles in Innovation Journeys: A Cultural-Performative Perspective and a Case Study of Dutch Nuclear Energy (1945–1986).” Technological Forecasting and Social Change 78 (6): 910–930. https://doi.org/10.1016/j.techfore.2010.12.004.
   Web of Science ®Google Scholar
• Geurts, Amber, Tara Geerdink, and Marit Sprenkeling. 2022. “Accelerated Innovation in Crises: The Role of Collaboration in the Development of Alternative Ventilators During the COVID-19 Pandemic.” Technology in Society 68 (February): 101923. https://doi.org/10.1016/j.techsoc.2022.101923.
   Google Scholar
• Gittelman, Michelle. 2016. “The Revolution Re-Visited: Clinical and Genetics Research Paradigms and the Productivity Paradox in Drug Discovery.” Research Policy 45 (8): 1570–1585. https://doi.org/10.1016/j.respol.2016.01.007
   Web of Science ®Google Scholar
• Gombocz, Margit, and Sabine Vogler. 2020. “Public Spending on Orphan Medicines: A Review of the Literature.” Journal of Pharmaceutical Policy and Practice 13 (1): 66. https://doi.org/10.1186/s40545-020-00260-0.
   PubMed Web of Science ®Google Scholar
• Gray, Barbara, Jill M. Purdy, and Shahzad (Shaz) Ansari. 2015. “From Interactions to Institutions: Microprocesses of Framing and Mechanisms for the Structuring of Institutional Fields.” Academy of Management Review 40 (1): 115–143. https://doi.org/10.5465/amr.2013.0299.
   Web of Science ®Google Scholar
• Hajer, Maarten A. 2002. “Discourse Coalitions and the Institutionalization of Practice: The Case of Acid Rain in Great Britain.” In Argument Turn Policy Anal Plan, edited by Frank Fischer, 51–84. London: Routledge.
   Google Scholar
• Haxeltine, Alex, René Kemp, Adina Dumitru, Flor Avelino, Bonno Pel, and Julia Wittmayer. 2015. “TRANSIT WP3 Deliverable D3.2 of 30 04 2015.” http://www.transitsocialinnovation.eu/content/original/Book%20covers/Local%20PDFs/161%20TRANSIT%20WP3%20deliverable%20D3.2%20of%2030%2004%202015%20v1.1(1).pdf.
   Google Scholar
• Heemstra, Harald E., Remco L. de Vrueh, Sonja van Weely, Hans A. Büller, and Hubert G. M. Leufkens. 2008. “Predictors of Orphan Drug Approval in the European Union.” European Journal of Clinical Pharmacology 64 (5): 545–552. https://doi.org/10.1007/s00228-007-0454-6.
   PubMed Web of Science ®Google Scholar
• Hogarth, Stuart. 2012. “Regulatory Experiments and Transnational Networks: The Governance of Pharmacogenomics in Europe and the United States.” Innovation: The European Journal of Social Science Research 25 (4): 441–460. https://doi.org/10.1080/13511610.2012.726423.
   Web of Science ®Google Scholar
• Holstein, James A., and Jaber F. Gubrium. 2016. “Narrative Practice and the Active Interview.” In Qualitative Data Analysis, edited by D. Silverman, 67–82. London: SAGE.
   Google Scholar
• Howaldt, Jürgen, Dmitri Domanski, and Christoph Kaletka. 2016. “Social Innovation: Towards a New Innovation Paradigm.” RAM. Revista de Administração Mackenzie 17 (6): 20–44. https://doi.org/10.1590/1678-69712016/administracao.v17n6p20-44.
   Google Scholar
• Howaldt, Jürgen, Christoph Kaletka, and Antonius Schröder. 2021. “A Research Agenda for Social Innovation – the Emergence of a Research Field.” In A Research Agenda for Social Innovation, edited by J. Howaldt, C. Kaletka, and A. Schröder, 1–17. Cheltenham: Edward Elgar Publishing.
   Google Scholar
• Jensen, H., and Barbara Fersch. 2019. “Institutional Entrepreneurs and Social Innovation in Danish Senior Care.” Administration & Society. https://doi.org/10.1177/0095399715624945
   Web of Science ®Google Scholar
• Johnson, Cathryn, Timothy J. Dowd, and Cecilia L. Ridgeway. 2006. “Legitimacy as a Social Process.” Annual Review of Sociology 32 (1): 53–78. https://doi.org/10.1146/annurev.soc.32.061604.123101.
   Web of Science ®Google Scholar
• King, Nigel, Christine Horrocks, and Joanna Brooks. 2018. Interviews in Qualitative Research. London: SAGE Publications Limited .
   Google Scholar
• Kleinhout-Vliek, Tineke. 2020. Weaving Necessity: Contextualisation Practices for Achieving Robust Health Care Coverage Decisions. Rotterdam: Erasmus University Rotterdam
   Google Scholar
• Kleinhout-Vliek, Tineke, Antoinette de Bont, and Bert Boer. 2021. “Necessity Under Construction – Societal Weighing Rationality in the Appraisal of Health Care Technologies.” Health Economics, Policy and Law 16 (4): 457–472. https://doi.org/10.1017/S1744133120000341.
   PubMed Web of Science ®Google Scholar
• Konrad, Kornelia. 2006. “The Social Dynamics of Expectations: The Interaction of Collective and Actor-Specific Expectations on Electronic Commerce and Interactive Television.” Technology Analysis & Strategic Management 18 (3-4): 429–444. https://doi.org/10.1080/09537320600777192.
   Web of Science ®Google Scholar
• Lamont, Michèle. 2012. “Toward a Comparative Sociology of Valuation and Evaluation.” Annual Review of Sociology 38 (1): 201–221. https://doi.org/10.1146/annurev-soc-070308-120022.
   Web of Science ®Google Scholar
• Lamont, Michèle, and Laurent Thévenot, eds. 2000. Rethinking Comparative Cultural Sociology: Repertoires of Evaluation in France and the United States. Cambridge Cultural Social Studies. Cambridge, UK; New York: Cambridge University Press.
   Google Scholar
• Latour, Bruno. 2007. Reassembling the Social: An Introduction to Actor-Network-Theory. Oxford: OUP.
   Google Scholar
• Law, John, and John Hassard. 1999. “Actor Network Theory and After.”
   Google Scholar
• Lee, Ruby P., Jelena Spanjol, and Sunny Li Sun. 2019. “Social Innovation in an Interconnected World: Introduction to the Special Issue.” Journal of Product Innovation Management 36 (6): 662–670. https://doi.org/10.1111/jpim.12513.
   Web of Science ®Google Scholar
• Luzzatto, Lucio, Hanna I. Hyry, Arrigo Schieppati, Enrico Costa, Steven Simoens, Franz Schaefer, Jonathan C. P. Roos, et al. 2018. “Outrageous Prices of Orphan Drugs: A Call for Collaboration.” The Lancet 392 (10149): 791–794. https://doi.org/10.1016/S0140-6736(18)31069-9.
   PubMed Web of Science ®Google Scholar
• Martin, Paul A. 2022. “The Challenge of Institutionalised Complicity: Researching the Pharmaceutical Industry in the Era of Impact and Engagement.” Sociology of Health & Illness 44 (S1): 158–178. https://doi.org/10.1111/1467-9566.13536.
   PubMedGoogle Scholar
• Mestre-Ferrandiz, Jorge, Christina Palaska, Tom Kelly, Adam Hutchings, and Adam Parnaby. 2019. “An Analysis of Orphan Medicine Expenditure in Europe: Is It Sustainable?” Orphanet Journal of Rare Diseases 14 (1): 287. https://doi.org/10.1186/s13023-019-1246-7.
   PubMed Web of Science ®Google Scholar
• Meyer, John, and Brian Rowan. 1977. “Institutionalized Organizations: Formal Structure as Myth and Ceremony.” American Journal of Sociology 83 (2): 340–363. https://doi.org/10.1086/226550.
   Web of Science ®Google Scholar
• Mikami, Koichi. 2019. “Orphans in the Market: The History of Orphan Drug Policy.” Social History of Medicine 32 (3): 609–630. https://doi.org/10.1093/shm/hkx098.
   PubMed Web of Science ®Google Scholar
• Mills, Jane, Ann Bonner, and Karen Francis. 2006. “The Development of Constructivist Grounded Theory.” International Journal of Qualitative Methods 5 (1): 25–35. https://doi.org/10.1177/160940690600500103.
   Google Scholar
• Molecke, Greg, and Jonatan Pinkse. 2020. “Justifying Social Impact as a Form of Impression Management: Legitimacy Judgements of Social Enterprises’ Impact Accounts.” British Journal of Management 31 (2): 387–402. https://doi.org/10.1111/1467-8551.12397.
   Web of Science ®Google Scholar
• Moors, Ellen HM, Adam F. Cohen, and Huub Schellekens. 2014. “Towards a Sustainable System of Drug Development.” Drug Discovery Today 19 (11): 1711–1720. https://doi.org/10.1016/j.drudis.2014.03.004.
   PubMed Web of Science ®Google Scholar
• Moulaert, Frank, Flavia Martinelli, Erik Swyngedouw, and Sara Gonzalez. 2005. “Towards Alternative Model(s) of Local Innovation.” Urban Studies 42 (11): 1969–1990. https://doi.org/10.1080/00420980500279893.
   Web of Science ®Google Scholar
• Mumford, Michael D. 2002. “Social Innovation: Ten Cases from Benjamin Franklin.” Creativity Research Journal 14 (2): 253–266. https://doi.org/10.1207/S15326934CRJ1402_11.
   Web of Science ®Google Scholar
• Oldenhof, Lieke, Jeroen Postma, and Kim Putters. 2014. “On Justification Work: How Compromising Enables Public Managers to Deal with Conflicting Values.” Public Administration Review 74 (1): 52–63. https://doi.org/10.1111/puar.12153.
   Web of Science ®Google Scholar
• Pel, Bonno, Alex Haxeltine, Flor Avelino, Adina Dumitru, René Kemp, Tom Bauler, Iris Kunze, Jens Dorland, Julia Wittmayer, and Michael Søgaard Jørgensen. 2020. “Towards a Theory of Transformative Social Innovation: A Relational Framework and 12 Propositions.” Research Policy 49 (8): 104080. https://doi.org/10.1016/j.respol.2020.104080.
   Web of Science ®Google Scholar
• Pinch, Trevor J., and Wiebe E. Bijker. 1984. “The Social Construction of Facts and Artefacts: Or How the Sociology of Science and the Sociology of Technology Might Benefit Each Other.” Social Studies of Science 14 (3): 399–441. https://doi.org/10.1177/030631284014003004.
   Web of Science ®Google Scholar
• Ragin, Charles C. 2004. “Turning the Tables: How Case-Oriented Research Challenges Variable-Oriented Research.” In Rethinking Social Inquiry: Diverse Tools, Shared Standards, edited by H. Brady and D. Collier, 123. Lanham: Rowman & Littlefield.
   Google Scholar
• Rip, Arie. 1986. “Controversies as Informal Technology Assessment.” Knowledge 8 (2): 349–371. https://doi.org/10.1177/107554708600800216.
   Google Scholar
• Rosanvallon, Pierre. 2011. Democratic Legitimacy: Impartiality, Reflexivity, Proximity. Democratic Legitimacy. Princeton: Princeton University Press. https://doi.org/10.1515/9781400838745.
   Google Scholar
• Sabato, Sebastiano, Bart Vanhercke, and Gert Verschraegen. 2017. “Connecting Entrepreneurship with Policy Experimentation? The EU Framework for Social Innovation.” Innovation: The European Journal of Social Science Research 30 (2): 147–167. https://doi.org/10.1080/13511610.2017.1282308.
   Web of Science ®Google Scholar
• Schellekens, Huub, Mohammed Aldosari, Herre Talsma, and Enrico Mastrobattista. 2017. “Making Individualized Drugs a Reality.” Nature Biotechnology 35 (6): 507–513. https://doi.org/10.1038/nbt.3888.
   PubMed Web of Science ®Google Scholar
• Schieppati, Arrigo, Jan-Inge Henter, Erica Daina, and Anita Aperia. 2008. “Why Rare Diseases Are an Important Medical and Social Issue.” The Lancet 371 (9629): 2039–2041. https://doi.org/10.1016/S0140-6736(08)60872-7.
   PubMed Web of Science ®Google Scholar
• Schuurmans, Jitse, Hanna Stalenhoef, Roland Bal, and Iris Wallenburg. 2023. “All the Good Care: Valuation and Task Differentiation in Older Person Care.” Sociology of Health & Illness 45: 1560–1577. https://doi.org/10.1111/1467-9566.13654.
   PubMed Web of Science ®Google Scholar
• Smith, Adrian, and Rob Raven. 2012. “What is Protective Space? Reconsidering Niches in Transitions to Sustainability.” Research Policy 41 (6): 1025–1036. https://doi.org/10.1016/j.respol.2011.12.012
   Web of Science ®Google Scholar
• Solis-Navarrete, José Alberto, Saray Bucio-Mendoza, and Jaime Paneque-Gálvez. 2021. “What is Not Social Innovation.” Technological Forecasting and Social Change 173 (December): 121190. https://doi.org/10.1016/j.techfore.2021.121190.
   Google Scholar
• Stryker, Robin. 1994. “Rules, Resources, and Legitimacy Processes: Some Implications for Social Conflict, Order, and Change.” American Journal of Sociology 99 (4): 847–910. https://doi.org/10.1086/230366.
   Web of Science ®Google Scholar
• Suchman, Mark C. 1995. “Managing Legitimacy: Strategic and Institutional Approaches.” The Academy of Management Review 20 (3): 571–610. https://doi.org/10.2307/258788.
   Web of Science ®Google Scholar
• Suddaby, Roy, Alex Bitektine, and Patrick Haack. 2017. “Legitimacy.” Academy of Management Annals 11 (1): 451–478. https://doi.org/10.5465/annals.2015.0101.
   Web of Science ®Google Scholar
• Tambuyzer, Erik, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay Davies, Stephen C. Groft, and Robert Preti. 2020. “Therapies for Rare Diseases: Therapeutic Modalities, Progress and Challenges Ahead.” Nature Reviews Drug Discovery 19 (2): 93–111. https://doi.org/10.1038/s41573-019-0049-9.
   PubMed Web of Science ®Google Scholar
• Thune, Taran, and Andrea Mina. 2016. “Hospitals as Innovators in the Health-Care System: A Literature Review and Research Agenda.” Research Policy 45 (8): 1545–1557. https://doi.org/10.1016/j.respol.2016.03.010.
   Web of Science ®Google Scholar
• Trouiller, Patrice, Piero Olliaro, Els Torreele, James Orbinski, Richard Laing, and Nathan Ford. 2002. “Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure.” The Lancet 359 (9324): 2188–2194. https://doi.org/10.1016/S0140-6736(02)09096-7.
   PubMed Web of Science ®Google Scholar
• van der Have, Robert P, and Luis Rubalcaba. 2016. “Social Innovation Research: An Emerging Area of Innovation Studies?” Research Policy 45 (9): 1923–1935. https://doi.org/10.1016/j.respol.2016.06.010.
   Web of Science ®Google Scholar
• van Lente, Harro. 2012. “Navigating Foresight in a Sea of Expectations: Lessons from the Sociology of Expectations.” Technology Analysis & Strategic Management 24 (8): 769–782. https://doi.org/10.1080/09537325.2012.715478.
   Web of Science ®Google Scholar
• van Niekerk, Lindi, N. Fosiko, A. Likaka, C. P. Blauveldt, B. Msiska, and L. Manderson. 2023. “From Idea to Systems Solution: Enhancing Access to Primary Care in Malawi.” BMC Health Services Research 23 (1): 547. https://doi.org/10.1186/s12913-023-09349-z.
   PubMed Web of Science ®Google Scholar
• van Niekerk, Lindi, Lenore Manderson, and Dina Balabanova. 2021. “The Application of Social Innovation in Healthcare: A Scoping Review.” Infectious Diseases of Poverty 10 (1): 26. https://doi.org/10.1186/s40249-021-00794-8.
   PubMed Web of Science ®Google Scholar
• Verleye, Katrien, Helen Perks, Thorsten Gruber, and Joris Voets. 2019. “The Long and Winding Road: Building Legitimacy for Complex Social Innovation in Networks.” Journal of Product Innovation Management 36 (6): 695–720. https://doi.org/10.1111/jpim.12506.
   Web of Science ®Google Scholar
• Vreman, Rick A., Aukje K. Mantel-Teeuwisse, Anke M. Hövels, Hubert G. M. Leufkens, and Wim G. Goettsch. 2020. “Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.” Value in Health 23 (1): 10–16. https://doi.org/10.1016/j.jval.2019.07.017.
   PubMed Web of Science ®Google Scholar
• Wadmann, Sarah, Amalie Martinus Hauge, and Laura Emdal Navne. 2023. “Good Conduct in a Context of Rationing: A Case Study of How Frontline Professionals Deal with Distributive Dilemmas of Novel Gene Therapies.” Sociology of Health & Illness 45 (3): 684–704. https://doi.org/10.1111/1467-9566.13608.
   PubMed Web of Science ®Google Scholar
• Weber, M. 1978. Economy and Society, Volume I & II. Edited by G. Roth and C. Wittich. Berkeley, CA: University of California Press. (Original work published 1924).
   Google Scholar
• Weber, K. Matthias, and Harald Rohracher. 2012. “Legitimizing Research, Technology and Innovation Policies for Transformative Change: Combining Insights from Innovation Systems and Multi-Level Perspective in a Comprehensive “Failures” Framework.” Research Policy, Special Section on Sustainability Transitions 41 (6): 1037–1047. https://doi.org/10.1016/j.respol.2011.10.015.
   Web of Science ®Google Scholar
• Witkamp, Marten J., Rob P. J. M. Raven, and Lambèr M. M. Royakkers. 2011. “Strategic Niche Management of Social Innovations: The Case of Social Entrepreneurship.” Technology Analysis & Strategic Management 23 (6): 667–681. https://doi.org/10.1080/09537325.2011.585035.
   Web of Science ®Google Scholar
• Wittmayer, Julia M., Julia Backhaus, Flor Avelino, Bonno Pel, Tim Strasser, Iris Kunze, and Linda Zuijderwijk. 2019. “Narratives of Change: How Social Innovation Initiatives Construct Societal Transformation.” Futures 112 (September): 102433. https://doi.org/10.1016/j.futures.2019.06.005.
   Google Scholar
• Zelditch, Morris. 2001. “Theories of Legitimacy.” In The Psychology of Legitimacy: Emerging Perspectives on Ideology, Justice, and Intergroup Relations, edited by J.T. Jost and B. Major, 33–53. Cambridge: Cambridge University Press.
   Google Scholar
• Ziegler, Rafael. 2017. “Social Innovation as a Collaborative Concept.” Innovation: The European Journal of Social Science Research 30 (4): 388–405. https://doi.org/10.1080/13511610.2017.1348935.
   Web of Science ®Google Scholar
• Zuckerman, Ezra W. 1999. “The Categorical Imperative: Securities Analysts and the Illegitimacy Discount.” American Journal of Sociology 104 (5): 1398–1438. https://doi.org/10.1086/210178.
   Web of Science ®Google Scholar